Dr. Limin Wang
China
IMBA
Dr. Limin Wang pursued her MBA at Bar Ilan University. She is a graduate of Peking University, majoring in material chemistry, and completed her Ph.D. in chemistry at the University of Pennsylvania. She has developed a number of novel radiopharmaceuticals for early diagnosis of prostate cancer and was a QED Proof-of-Concept fellow at the University Science Center in Philadelphia investigating novel assay for early diagnosis of pancreatic cancer.
While in Israel, Dr. Limin Wang served as an Intellectual Property Scientific Associate at Dr. Eyal Bressler & Co., and trained to be an Israeli patent lawyer. In her work at Dr. Eyal Bressler & Co., Limin provided both technical and legal analysis of patents and patent strategies, and drafted and negotiated complex patent applications.
Interested in the field of technology transfer and intellectual property protection, Limin aimed to manage the patent portfolios of pharmaceutical or biotechnology companies looking to transfer or commercialize cutting-edge Israeli technologies to China.
During the fellowship, Limin focused on identifying potential challenges facing Israeli companies in technology transfer and commercializing technologies in China. Limin then joined the Israel Export & International Cooperation Institute where she served as the as Manager of the China Unit.
Limin is currently the General Manager of DayDayUp Israel, establishing a “China Hub” connecting Israel and China innovation ecosystem.
